Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8145 |
Intermediate Similarity |
NPD5631 |
Phase 3 |
0.7752 |
Intermediate Similarity |
NPD5657 |
Phase 3 |
0.7744 |
Intermediate Similarity |
NPD1937 |
Approved |
0.7571 |
Intermediate Similarity |
NPD1883 |
Approved |
0.7538 |
Intermediate Similarity |
NPD7480 |
Approved |
0.7538 |
Intermediate Similarity |
NPD7481 |
Approved |
0.75 |
Intermediate Similarity |
NPD3546 |
Approved |
0.75 |
Intermediate Similarity |
NPD3545 |
Approved |
0.7463 |
Intermediate Similarity |
NPD3623 |
Clinical (unspecified phase) |
0.7463 |
Intermediate Similarity |
NPD3622 |
Clinical (unspecified phase) |
0.7462 |
Intermediate Similarity |
NPD6069 |
Approved |
0.7462 |
Intermediate Similarity |
NPD6070 |
Approved |
0.744 |
Intermediate Similarity |
NPD4114 |
Approved |
0.744 |
Intermediate Similarity |
NPD6299 |
Approved |
0.744 |
Intermediate Similarity |
NPD6300 |
Approved |
0.744 |
Intermediate Similarity |
NPD4115 |
Approved |
0.7426 |
Intermediate Similarity |
NPD2840 |
Approved |
0.7413 |
Intermediate Similarity |
NPD1864 |
Clinical (unspecified phase) |
0.7413 |
Intermediate Similarity |
NPD1870 |
Approved |
0.7413 |
Intermediate Similarity |
NPD1866 |
Approved |
0.7397 |
Intermediate Similarity |
NPD6017 |
Discontinued |
0.7379 |
Intermediate Similarity |
NPD6301 |
Phase 2 |
0.7364 |
Intermediate Similarity |
NPD2913 |
Approved |
0.7364 |
Intermediate Similarity |
NPD2914 |
Approved |
0.7361 |
Intermediate Similarity |
NPD4450 |
Approved |
0.7361 |
Intermediate Similarity |
NPD4451 |
Approved |
0.7347 |
Intermediate Similarity |
NPD5839 |
Clinical (unspecified phase) |
0.7343 |
Intermediate Similarity |
NPD2733 |
Approved |
0.7324 |
Intermediate Similarity |
NPD1998 |
Approved |
0.7323 |
Intermediate Similarity |
NPD1539 |
Approved |
0.7302 |
Intermediate Similarity |
NPD5253 |
Approved |
0.7297 |
Intermediate Similarity |
NPD1886 |
Approved |
0.7292 |
Intermediate Similarity |
NPD2304 |
Approved |
0.7292 |
Intermediate Similarity |
NPD3276 |
Approved |
0.7273 |
Intermediate Similarity |
NPD4411 |
Phase 1 |
0.7273 |
Intermediate Similarity |
NPD3864 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD4410 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD4463 |
Approved |
0.7267 |
Intermediate Similarity |
NPD4462 |
Approved |
0.7266 |
Intermediate Similarity |
NPD4019 |
Clinical (unspecified phase) |
0.726 |
Intermediate Similarity |
NPD5020 |
Approved |
0.7254 |
Intermediate Similarity |
NPD3385 |
Approved |
0.7244 |
Intermediate Similarity |
NPD477 |
Phase 1 |
0.7244 |
Intermediate Similarity |
NPD2678 |
Approved |
0.7244 |
Intermediate Similarity |
NPD2679 |
Approved |
0.7239 |
Intermediate Similarity |
NPD1525 |
Approved |
0.7231 |
Intermediate Similarity |
NPD5181 |
Approved |
0.7231 |
Intermediate Similarity |
NPD5179 |
Approved |
0.7231 |
Intermediate Similarity |
NPD5180 |
Approved |
0.7219 |
Intermediate Similarity |
NPD2882 |
Phase 1 |
0.7214 |
Intermediate Similarity |
NPD3654 |
Approved |
0.7211 |
Intermediate Similarity |
NPD4637 |
Clinical (unspecified phase) |
0.7211 |
Intermediate Similarity |
NPD6506 |
Clinical (unspecified phase) |
0.7209 |
Intermediate Similarity |
NPD2999 |
Approved |
0.7209 |
Intermediate Similarity |
NPD3001 |
Approved |
0.7206 |
Intermediate Similarity |
NPD478 |
Approved |
0.719 |
Intermediate Similarity |
NPD7091 |
Discontinued |
0.7188 |
Intermediate Similarity |
NPD1107 |
Approved |
0.7188 |
Intermediate Similarity |
NPD4116 |
Approved |
0.7188 |
Intermediate Similarity |
NPD1108 |
Approved |
0.7181 |
Intermediate Similarity |
NPD7469 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD1865 |
Approved |
0.7121 |
Intermediate Similarity |
NPD2622 |
Approved |
0.712 |
Intermediate Similarity |
NPD2244 |
Clinical (unspecified phase) |
0.7105 |
Intermediate Similarity |
NPD5663 |
Discontinued |
0.7105 |
Intermediate Similarity |
NPD6707 |
Clinical (unspecified phase) |
0.7099 |
Intermediate Similarity |
NPD2659 |
Approved |
0.7099 |
Intermediate Similarity |
NPD2658 |
Approved |
0.7099 |
Intermediate Similarity |
NPD3147 |
Approved |
0.7099 |
Intermediate Similarity |
NPD3150 |
Approved |
0.7099 |
Intermediate Similarity |
NPD3148 |
Approved |
0.7099 |
Intermediate Similarity |
NPD3149 |
Approved |
0.7092 |
Intermediate Similarity |
NPD4300 |
Clinical (unspecified phase) |
0.7083 |
Intermediate Similarity |
NPD2292 |
Approved |
0.708 |
Intermediate Similarity |
NPD1498 |
Approved |
0.7068 |
Intermediate Similarity |
NPD2467 |
Approved |
0.7068 |
Intermediate Similarity |
NPD2464 |
Approved |
0.7068 |
Intermediate Similarity |
NPD2463 |
Approved |
0.7054 |
Intermediate Similarity |
NPD7633 |
Discontinued |
0.705 |
Intermediate Similarity |
NPD1949 |
Approved |
0.705 |
Intermediate Similarity |
NPD1950 |
Approved |
0.704 |
Intermediate Similarity |
NPD1417 |
Approved |
0.704 |
Intermediate Similarity |
NPD1419 |
Approved |
0.7037 |
Intermediate Similarity |
NPD2212 |
Approved |
0.7037 |
Intermediate Similarity |
NPD2210 |
Approved |
0.7032 |
Intermediate Similarity |
NPD7735 |
Clinical (unspecified phase) |
0.7031 |
Intermediate Similarity |
NPD2243 |
Clinical (unspecified phase) |
0.7023 |
Intermediate Similarity |
NPD1762 |
Approved |
0.7023 |
Intermediate Similarity |
NPD1764 |
Approved |
0.7007 |
Intermediate Similarity |
NPD1904 |
Approved |
0.7007 |
Intermediate Similarity |
NPD1902 |
Approved |
0.6984 |
Remote Similarity |
NPD5103 |
Approved |
0.698 |
Remote Similarity |
NPD4047 |
Discontinued |
0.6978 |
Remote Similarity |
NPD4985 |
Clinical (unspecified phase) |
0.6972 |
Remote Similarity |
NPD4857 |
Phase 1 |
0.6963 |
Remote Similarity |
NPD1903 |
Approved |
0.6957 |
Remote Similarity |
NPD7461 |
Approved |
0.6953 |
Remote Similarity |
NPD990 |
Approved |
0.6953 |
Remote Similarity |
NPD993 |
Approved |
0.695 |
Remote Similarity |
NPD995 |
Clinical (unspecified phase) |
0.6948 |
Remote Similarity |
NPD2732 |
Approved |
0.6939 |
Remote Similarity |
NPD2323 |
Clinical (unspecified phase) |
0.6929 |
Remote Similarity |
NPD6900 |
Discontinued |
0.6923 |
Remote Similarity |
NPD3548 |
Approved |
0.6918 |
Remote Similarity |
NPD5744 |
Clinical (unspecified phase) |
0.6917 |
Remote Similarity |
NPD5629 |
Discontinued |
0.6913 |
Remote Similarity |
NPD5527 |
Clinical (unspecified phase) |
0.6913 |
Remote Similarity |
NPD5526 |
Phase 2 |
0.6913 |
Remote Similarity |
NPD1592 |
Phase 3 |
0.6908 |
Remote Similarity |
NPD5881 |
Clinical (unspecified phase) |
0.6903 |
Remote Similarity |
NPD6285 |
Phase 2 |
0.6897 |
Remote Similarity |
NPD2791 |
Discontinued |
0.6892 |
Remote Similarity |
NPD2093 |
Discontinued |
0.6892 |
Remote Similarity |
NPD1953 |
Discontinued |
0.6887 |
Remote Similarity |
NPD5995 |
Clinical (unspecified phase) |
0.6883 |
Remote Similarity |
NPD6158 |
Phase 2 |
0.6883 |
Remote Similarity |
NPD6476 |
Clinical (unspecified phase) |
0.6883 |
Remote Similarity |
NPD3306 |
Approved |
0.6879 |
Remote Similarity |
NPD1516 |
Approved |
0.6875 |
Remote Similarity |
NPD3137 |
Clinical (unspecified phase) |
0.6871 |
Remote Similarity |
NPD45 |
Approved |
0.6871 |
Remote Similarity |
NPD6554 |
Approved |
0.6863 |
Remote Similarity |
NPD5546 |
Clinical (unspecified phase) |
0.6859 |
Remote Similarity |
NPD6396 |
Clinical (unspecified phase) |
0.6859 |
Remote Similarity |
NPD6395 |
Phase 2 |
0.6857 |
Remote Similarity |
NPD6320 |
Approved |
0.6855 |
Remote Similarity |
NPD5140 |
Approved |
0.6855 |
Remote Similarity |
NPD5138 |
Approved |
0.6853 |
Remote Similarity |
NPD1001 |
Discontinued |
0.6846 |
Remote Similarity |
NPD1721 |
Clinical (unspecified phase) |
0.6846 |
Remote Similarity |
NPD3943 |
Clinical (unspecified phase) |
0.6842 |
Remote Similarity |
NPD1683 |
Approved |
0.6831 |
Remote Similarity |
NPD4895 |
Clinical (unspecified phase) |
0.6828 |
Remote Similarity |
NPD7200 |
Approved |
0.6824 |
Remote Similarity |
NPD6606 |
Clinical (unspecified phase) |
0.6822 |
Remote Similarity |
NPD1065 |
Approved |
0.6822 |
Remote Similarity |
NPD1064 |
Approved |
0.6821 |
Remote Similarity |
NPD5060 |
Phase 1 |
0.6821 |
Remote Similarity |
NPD5595 |
Clinical (unspecified phase) |
0.6815 |
Remote Similarity |
NPD1344 |
Phase 2 |
0.6815 |
Remote Similarity |
NPD6660 |
Discontinued |
0.6815 |
Remote Similarity |
NPD4326 |
Phase 2 |
0.6813 |
Remote Similarity |
NPD2915 |
Discontinued |
0.6806 |
Remote Similarity |
NPD3475 |
Approved |
0.6806 |
Remote Similarity |
NPD3476 |
Approved |
0.68 |
Remote Similarity |
NPD4430 |
Phase 2 |
0.68 |
Remote Similarity |
NPD4464 |
Clinical (unspecified phase) |
0.6797 |
Remote Similarity |
NPD4432 |
Discontinued |
0.6791 |
Remote Similarity |
NPD1813 |
Discontinued |
0.6788 |
Remote Similarity |
NPD3498 |
Approved |
0.6788 |
Remote Similarity |
NPD3499 |
Approved |
0.6781 |
Remote Similarity |
NPD1859 |
Approved |
0.6772 |
Remote Similarity |
NPD4735 |
Approved |
0.6772 |
Remote Similarity |
NPD4734 |
Approved |
0.6768 |
Remote Similarity |
NPD5065 |
Approved |
0.6765 |
Remote Similarity |
NPD6141 |
Clinical (unspecified phase) |
0.6763 |
Remote Similarity |
NPD270 |
Clinical (unspecified phase) |
0.6763 |
Remote Similarity |
NPD271 |
Approved |
0.6763 |
Remote Similarity |
NPD7462 |
Clinical (unspecified phase) |
0.6763 |
Remote Similarity |
NPD268 |
Approved |
0.6763 |
Remote Similarity |
NPD2389 |
Approved |
0.6755 |
Remote Similarity |
NPD2866 |
Approved |
0.6752 |
Remote Similarity |
NPD2326 |
Approved |
0.6744 |
Remote Similarity |
NPD563 |
Approved |
0.6744 |
Remote Similarity |
NPD564 |
Approved |
0.6739 |
Remote Similarity |
NPD2340 |
Discontinued |
0.6738 |
Remote Similarity |
NPD2143 |
Discontinued |
0.6736 |
Remote Similarity |
NPD1500 |
Approved |
0.6736 |
Remote Similarity |
NPD5782 |
Phase 3 |
0.6728 |
Remote Similarity |
NPD5069 |
Clinical (unspecified phase) |
0.6725 |
Remote Similarity |
NPD4334 |
Discontinued |
0.6725 |
Remote Similarity |
NPD6965 |
Clinical (unspecified phase) |
0.6716 |
Remote Similarity |
NPD23 |
Approved |
0.6713 |
Remote Similarity |
NPD2036 |
Approved |
0.6711 |
Remote Similarity |
NPD4711 |
Clinical (unspecified phase) |
0.6711 |
Remote Similarity |
NPD5933 |
Phase 3 |
0.6711 |
Remote Similarity |
NPD5254 |
Discontinued |
0.6711 |
Remote Similarity |
NPD7017 |
Clinical (unspecified phase) |
0.6711 |
Remote Similarity |
NPD5932 |
Phase 3 |
0.6711 |
Remote Similarity |
NPD5931 |
Phase 3 |
0.671 |
Remote Similarity |
NPD6575 |
Clinical (unspecified phase) |
0.6708 |
Remote Similarity |
NPD4550 |
Clinical (unspecified phase) |
0.6708 |
Remote Similarity |
NPD3363 |
Clinical (unspecified phase) |
0.6707 |
Remote Similarity |
NPD4112 |
Clinical (unspecified phase) |
0.6707 |
Remote Similarity |
NPD5078 |
Clinical (unspecified phase) |
0.6707 |
Remote Similarity |
NPD6452 |
Discontinued |
0.6707 |
Remote Similarity |
NPD5996 |
Clinical (unspecified phase) |
0.6692 |
Remote Similarity |
NPD2039 |
Approved |
0.6692 |
Remote Similarity |
NPD2038 |
Approved |
0.669 |
Remote Similarity |
NPD1858 |
Approved |
0.669 |
Remote Similarity |
NPD1502 |
Approved |
0.6687 |
Remote Similarity |
NPD1325 |
Approved |
0.6687 |
Remote Similarity |
NPD1326 |
Approved |
0.6667 |
Remote Similarity |
NPD3434 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD3424 |
Clinical (unspecified phase) |
0.6646 |
Remote Similarity |
NPD6855 |
Clinical (unspecified phase) |
0.6646 |
Remote Similarity |
NPD5934 |
Clinical (unspecified phase) |
0.6646 |
Remote Similarity |
NPD2468 |
Approved |
0.6646 |
Remote Similarity |
NPD2469 |
Approved |
0.6645
|
Remote Similarity |
NPD1183 |
Approved |